| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0004 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |